PT Kalbe Farma Tbk 2016 AR2
The report highlights PT Kalbe Farma Tbk's performance in 2016, marking its 50th anniversary. The company achieved net sales growth of 8.3% to Rp19.4 trillion, driven by volume growth across all business divisions. Key achievements included completing a new biological medicine factory under PT Kalbio Global Medika and launching several new products. In sustainability, Kalbe engaged in community development through its 'Kalbe Berbagi' program, reaching over 358,000 environmental beneficiaries, and implemented energy efficiency initiatives that saved over 2 million kWh of electricity.
Company: PT Kalbe Farma Tbk
Sector: Health Care
Country: Indonesia
Year: 2016
Type: AR2
Pages: 453
Back to company
PT Kalbe Farma Tbk
Annual Report
The report highlights PT Kalbe Farma Tbk's performance in 2016, marking its 50th anniversary. The company achieved net sales growth of 8.3% to Rp19.4 trillion, driven by volume growth across all business divisions. Key achievements included completing a new biological medicine factory under PT Kalbio Global Medika and launching several new products. In sustainability, Kalbe engaged in community development through its 'Kalbe Berbagi' program, reaching over 358,000 environmental beneficiaries, and implemented energy efficiency initiatives that saved over 2 million kWh of electricity.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2016
Reporting Period
Jan 1, 2016 - Dec 31, 2016
Fiscal Year
2016
Type
Annual Report with Sustainability Disclosures
Language
English, Indonesian
Pages
File Size
Standards & Assurance
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Women on Board
Employees